Richard Mcgivney

Rich McGivney is a CPA and financial executive with more than 30 years of experience spanning public accounting, corporate finance, and operational leadership. He holds an M.S. in Accounting from Appalachian State University in Boone, North Carolina. Over his career he has built and managed finance functions across organizations ranging from entrepreneurial startups to companies with more than 1,000 employees, including executing strategic realignments, multiple acquisitions and divestitures, and the expansion of finance operations overseas.

His operating history includes senior finance roles such as Audit Partner at Nelson and Company, P.A.; Vice President of Finance and Corporate Controller at RTI International (Research Triangle Institute), an organization of roughly 5,000 employees; Chief Financial Officer at Innovative Emergency Management (IEM); and Chief Financial Officer at Lovelace Respiratory Research Institute (LRRI), which employed around 1,100 people. Much of his experience involves federal government contracting environments (HHS, DoD, DHS, EPA) and research and technical-services organizations.

Today he is a Partner at Rankin McKenzie, a firm founded long ago and now structured as a partnership of 30+ seasoned CFOs and controllers (each with 15+ years of experience) that has served more than 600 clients. The firm provides fractional and interim CFO and controller services, strategic financial planning, cash-flow optimization, M&A advisory, and support for capital and equity fundraising. In this role McGivney has worked with early-stage life-science and technology companies — most recently Susteon, a climate-impact technology venture — helping them develop and execute strategic plans, raise capital, and hire key staff.

Note on classification: the source stub categorizes McGivney as an "Angel Investor" investing at the seed round. Available primary sources (his firm bio, LinkedIn, and the firm site) present him as a fractional/interim CFO and capital-raising advisor to startups, not as a personal angel investor with a documented investment portfolio. Founders should treat the "angel" label with caution and confirm directly whether he deploys personal capital.

• Engages with seed and early-stage startups, primarily in life sciences/biotech, climate/clean-tech, and technology, the sectors where his firm and personal work are concentrated.
• His value-add is financial leadership and fundraising support — helping founders "develop and execute on strategic plans, including raising capital and hiring key staff," per his firm bio — rather than (verifiably) writing personal angel checks.
• Through Rankin McKenzie, the engagement model is fractional/interim CFO and controller services plus capital and equity fundraising assistance for growth companies.
• Strong fit for federal-contracting and research/technical-services businesses given his deep background with HHS, DoD, DHS, and EPA contracting.
• Check size is not publicly disclosed and is omitted here rather than guessed.